National Surgical Adjuvant Breast and Bowel Project R-@ was designed to determine whether the oral fluoropyrimidine capecitabine could be substituted for continuous infusion @-FU in the curative setting of stage II/III rectal cancer during neoadjuvant radiation therapy and whether the addition of oxaliplatin could further enhance the activity of fluoropyrimidine-sensitized radiation .